On 29 April 2026, Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) issued an overseas regulatory announcement pursuant to Rule 13.10B of the Hong Kong Listing Rules. The notice confirms that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange website.

The Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited expressly disclaim responsibility for the accuracy or completeness of the content.

Weigao Group’s board of directors is led by Chairman Long Jing and currently comprises four executive directors, two non-executive directors and four independent non-executive directors.

No additional financial or operational metrics were disclosed in the filing. The primary purpose of the announcement is to direct investors to the full text of the subsidiary’s disclosure available on the Shanghai Stock Exchange platform.